Cargando…
Artificial intelligence in oncologic imaging
Radiology is integral to cancer care. Compared to molecular assays, imaging has its advantages. Imaging as a noninvasive tool can assess the entirety of tumor unbiased by sampling error and is routinely acquired at multiple time points in oncological practice. Imaging data can be digitally post-proc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525817/ https://www.ncbi.nlm.nih.gov/pubmed/36193451 http://dx.doi.org/10.1016/j.ejro.2022.100441 |
_version_ | 1784800764422520832 |
---|---|
author | Chen, Melissa M. Terzic, Admir Becker, Anton S. Johnson, Jason M. Wu, Carol C. Wintermark, Max Wald, Christoph Wu, Jia |
author_facet | Chen, Melissa M. Terzic, Admir Becker, Anton S. Johnson, Jason M. Wu, Carol C. Wintermark, Max Wald, Christoph Wu, Jia |
author_sort | Chen, Melissa M. |
collection | PubMed |
description | Radiology is integral to cancer care. Compared to molecular assays, imaging has its advantages. Imaging as a noninvasive tool can assess the entirety of tumor unbiased by sampling error and is routinely acquired at multiple time points in oncological practice. Imaging data can be digitally post-processed for quantitative assessment. The ever-increasing application of Artificial intelligence (AI) to clinical imaging is challenging radiology to become a discipline with competence in data science, which plays an important role in modern oncology. Beyond streamlining certain clinical tasks, the power of AI lies in its ability to reveal previously undetected or even imperceptible radiographic patterns that may be difficult to ascertain by the human sensory system. Here, we provide a narrative review of the emerging AI applications relevant to the oncological imaging spectrum and elaborate on emerging paradigms and opportunities. We envision that these technical advances will change radiology in the coming years, leading to the optimization of imaging acquisition and discovery of clinically relevant biomarkers for cancer diagnosis, staging, and treatment monitoring. Together, they pave the road for future clinical translation in precision oncology. |
format | Online Article Text |
id | pubmed-9525817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95258172022-10-02 Artificial intelligence in oncologic imaging Chen, Melissa M. Terzic, Admir Becker, Anton S. Johnson, Jason M. Wu, Carol C. Wintermark, Max Wald, Christoph Wu, Jia Eur J Radiol Open Article Radiology is integral to cancer care. Compared to molecular assays, imaging has its advantages. Imaging as a noninvasive tool can assess the entirety of tumor unbiased by sampling error and is routinely acquired at multiple time points in oncological practice. Imaging data can be digitally post-processed for quantitative assessment. The ever-increasing application of Artificial intelligence (AI) to clinical imaging is challenging radiology to become a discipline with competence in data science, which plays an important role in modern oncology. Beyond streamlining certain clinical tasks, the power of AI lies in its ability to reveal previously undetected or even imperceptible radiographic patterns that may be difficult to ascertain by the human sensory system. Here, we provide a narrative review of the emerging AI applications relevant to the oncological imaging spectrum and elaborate on emerging paradigms and opportunities. We envision that these technical advances will change radiology in the coming years, leading to the optimization of imaging acquisition and discovery of clinically relevant biomarkers for cancer diagnosis, staging, and treatment monitoring. Together, they pave the road for future clinical translation in precision oncology. Elsevier 2022-09-29 /pmc/articles/PMC9525817/ /pubmed/36193451 http://dx.doi.org/10.1016/j.ejro.2022.100441 Text en © 2022 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Chen, Melissa M. Terzic, Admir Becker, Anton S. Johnson, Jason M. Wu, Carol C. Wintermark, Max Wald, Christoph Wu, Jia Artificial intelligence in oncologic imaging |
title | Artificial intelligence in oncologic imaging |
title_full | Artificial intelligence in oncologic imaging |
title_fullStr | Artificial intelligence in oncologic imaging |
title_full_unstemmed | Artificial intelligence in oncologic imaging |
title_short | Artificial intelligence in oncologic imaging |
title_sort | artificial intelligence in oncologic imaging |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525817/ https://www.ncbi.nlm.nih.gov/pubmed/36193451 http://dx.doi.org/10.1016/j.ejro.2022.100441 |
work_keys_str_mv | AT chenmelissam artificialintelligenceinoncologicimaging AT terzicadmir artificialintelligenceinoncologicimaging AT beckerantons artificialintelligenceinoncologicimaging AT johnsonjasonm artificialintelligenceinoncologicimaging AT wucarolc artificialintelligenceinoncologicimaging AT wintermarkmax artificialintelligenceinoncologicimaging AT waldchristoph artificialintelligenceinoncologicimaging AT wujia artificialintelligenceinoncologicimaging |